Global Single-use Bioprocessing Market Overview:
Disposable systems are such devices used for the production of biopharmaceuticals i.e. bio-processing, which are mainly intended for the purpose of single-use and then for subsequent disposal. Devices for disposable systems usually consist of plastic components that have been sterilized and sealed using gamma radiation. The market for single-use bioprocessing systems is thereby likely to grow owing to the increase in the demand for biologicals. Biopharmaceutical manufacturers are at the forefront of human responsibility towards the ongoing coronavirus pandemic. A significant number of large biotech companies are in the middle of a race to study the Sars Cov-2 genome and produce a suitable vaccine for it. Compared to the speed of response to SARS / MERs, etc., biotech companies are studying SARs-Cov-2 at an unprecedented rate, and a significant amount of research and development is being invested. The public and private sectors are also hereby expected to work together until the vaccine for Covid-19 is developed. This disposable technology has hereby become one of the leading technologies in the field of pre-commercial manufacturing, which also includes all the pre-clinical and clinical standards. In these recent years, the introduction of single-use bioprocessing-based process lines has widely increased to the extent wherein the method of single-use has dominated all the pre-commercial biopharmaceutical manufacturing. Most of the organic processing companies generally use a very significant amount of different single-use products, which thereby contribute towards the growth in the sales of the single-use organic processing market. The introduction of automation and intelligent organic production has also increased the efficiency of single-use bioprocessing exponentially. With technological advances, the penetration of this single-use bio-processing model is hereby expected to increase very significantly near future.
- Increasing Adoption Of Single-Use Tangential Flow Filters, Depth Filters, And Chromatography Columns
- The Increasing Expiry Of Patents Of Blockbuster Molecules And Rising Demand For Biologics
- Increasing Adoption Of Media Bags And Containers In Transportation And Storage Application
- The Rising Demand For Biopharmaceuticals, High Energy Efficiency, Low Water Usage, Less Floor Space Requirement, Very Low Risk Of Product Cross Contamination, And Faster To Implement
- Extractability And Leach Ability Issues Regarding Disposable Components Like Plastic Bags
- Environmental And Economic Concerns
- The Advent Of Intelligent Biomanufacturing And Automation, The Effectiveness Of These Processes Has Been Increased the Demand
- The Rising Technological Progress, Single-Use Bioprocessing Model Is Expected To Witness Augmented Expansion
- The Waste Disposal Of Single-Use Processes And Scaling-Up Issues
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Thermo Fisher Scientific (United States), Danaher Corporation (United States), GE Healthcare (United States), Sartorius AG (Germany), MilliporeSigma (United States), 3M Company (United States), Eppendorf AG (Germany), Finesse Solutions, Inc. (United States), Applikon Biotechnology B.V. (Netherlands) and Cesco Bioengineering Co., Ltd (Taiwan). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Single-use Bioprocessing market by 2025. Considering Market by End-User, the sub-segment i.e. Pharmaceutical Companies will boost the Single-use Bioprocessing market. Considering Market by By Workflow, the sub-segment i.e. Downstream will boost the Single-use Bioprocessing market.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Single-use Bioprocessing market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Single-use Bioprocessing market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Providers of Single-use Bioprocessing, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.